References
- Peltola H. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin Microbiol Rev 2000; 13:302–17.
- Peltola H, Kilpi T, Anttila M. Rapid disappearance of Haemophilus influenzae type b meningitis after routine childhood immunisation with conjugate vaccines. Lancet 1992; 340:592–4.
- Vadheim CM, Greenberg DP, Eriksen E, et al. Eradication of Haemophilus influenzae type b disease in southern California. Kaiser-UCLA Vaccine Study Group. Arch Pediatr Adolesc Med 1994; 148:51–6.
- McIntyre PB, Chey T, Smith WT. The impact of vaccination against invasive Haemophilus influenzae type b disease in the Sydney region. Med J Aust 1995; 162:245–8.
- Hornby P, Gilmour R, Wang H, McIntyre P. Progress towards eliminating Hib in Australia: an evaluation of Haemophilus influenzae type b prevention in Australia, 1 July 1993 to June 2000. Commun Dis Intell 2003; 27:324–41.
- Singleton R, Hammitt L, Hennessy T, et al. The Alaskan Haemophilus influenzae type b experience: lessons in controlling a vaccine-preventable disease. Pediatrics 2006; 118: e421–9.
- Wilson N, Wenger J, Mansoor O, Baker M, Martin D. The beneficial impact of Hib vaccine on disease rates in New Zealand children. N Z Med J 2002; 115: U122.
- Dagan R, Fraser D, Roitman M, et al. Effectiveness of a nationwide infant immunization program against Haemophilus influenzae b. The Israeli Pediatric Bacteremia and Meningitis Group. Vaccine 1999; 17:134–41.
- van Alphen L, Spanjaard L, van der Ende A, Schuurman I, Dankert J. Effect of nationwide vaccination of 3-month-old infants in The Netherlands with conjugate Haemophilus influenzae type b vaccine: high efficacy and lack of herd immunity. J Pediatr 1997; 131:869–73.
- Adegbola RA, Secka O, Lahai G, et al. Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study. Lancet 2005; 366:144–50.
- Cowgill KD, Ndiritu M, Nyiro J, et al. Effectiveness of Haemophilus influenzae type b conjugate vaccine introduction into routine childhood immunization in Kenya. JAMA 2006; 296:671–8.
- Ribeiro GS, Lima JB, Reis JN, et aliHaemophilus influenzae meningitis 5 years after introduction of the Haemophilus influenzae type b conjugate vaccine in Brazil. Vaccine 2007; 25:4420–8.
- Wilson N, Mansoor O, Wenger J, et al. Estimating the Haemophilus influenzae type b (Hib) disease burden and the impact of Hib vaccine in Fiji. Vaccine 2003; 21:1907–12.
- Baqui AH, El Arifeen S, Saha S, et al. Effectiveness of Haemophilus influenzae type B conjugate vaccine on prevention of pneumonia and meningitis in Bangladeshi children: a case-control study. Pediatr Infect Dis J 2007; 26:565–71.
- WHO position paper on Haemophilus influenzae type b conjugate vaccines. WHO Wkly Epidemiol Rec 2006; 47:445–52.
- Russell FM, Carapetis JR, Mansoor O, et al. High incidence of Haemophilus influenzae type b infection in children in Pacific island countries. Clin Infect Dis 2003; 37:1593–9.
- Ministry of Health, Tonga. Annual Report and the Reproductive Health Data and Indicators, 2006.
- Ladhani S, Slack MP, Heys M, White J, Ramsay ME. Fall in Haemophilus influenzae serotype b (Hib) disease following implementation of a booster campaign. Arch Dis Child 2008; 93:646–7.
- Howie SR, Antonio M, Akisanya A, et al. Reemergence of Haemophilus influenzae type b (Hib) disease in The Gambia following successful elimination with conjugate Hib vaccine. Vaccine 2007; 25:6305–9.